back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-14 Tx date 2019-01-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-207,237 vol |
805,747 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-189,626.58
-486,222 vol $0.39 each |
673,257 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$189,626
+486,222 vol $0.39 each |
3,114,353 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-36,592.5384
-72,792 vol $0.50 each |
||
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-36,592.5384
-72,792 vol $0.50 each |
1,159,479 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$36,592
+72,792 vol $0.50 each |
2,628,131 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-36,592.5384
-72,792 vol $0.50 each |
||
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-75,851.67
-41,449 vol $1.83 each |
1,232,271 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$75,851
+41,449 vol $1.83 each |
2,555,339 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+463,500 vol |
1,012,984 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$651,537
+486,222 vol $1.34 each |
2,513,890 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-651,537.48
-486,222 vol $1.34 each |
1,273,720 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+252,316 vol |
357,567 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+218,380 vol |
1,759,942 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+342,247 vol |
549,484 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$93,253
+41,446 vol $2.25 each |
2,027,668 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-93,253.50
-41,446 vol $2.25 each |
1,541,562 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,230,950
+500,000 vol $2.46 each |
1,986,222 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,930,301.34
-486,222 vol $3.97 each |
1,583,008 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,930,301
+486,222 vol $3.97 each |
1,486,222 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,251 vol |
105,251 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+207,237 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+207,237 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+207,237 vol |
207,237 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+124,342 vol |
2,069,230 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
1,944,888 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Adams, Adrian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,944,888 |